Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Neoplasm
100%
Surgery
74%
Stomach Cancer
60%
Malignant Neoplasm
54%
Percutaneous Coronary Intervention
53%
Disease
49%
Computer Assisted Tomography
47%
Retrospective Study
39%
Recurrent Disease
39%
Overall Survival
39%
Hepatectomy
37%
Bleeding
36%
Gastrectomy
35%
Magnetic Resonance Imaging
34%
Colorectal Cancer
32%
Aneurysm
31%
Odds Ratio
30%
Hazard Ratio
28%
Cohort Analysis
27%
Infection
27%
Surgeon
26%
Rectum Cancer
26%
Non Small Cell Lung Cancer
26%
COVID-19
26%
Survival Rate
26%
Intravascular Ultrasound
25%
Apoplexy
25%
Observational Study
25%
Diagnosis
22%
Metastatic Carcinoma
22%
Chronic Kidney Disease
21%
Liver Metastasis
21%
Coronary Artery Disease
20%
Stenosis
20%
Artery
20%
Adverse Event
20%
Echography
20%
Multivariate Analysis
20%
Cross Sectional Study
20%
Lung Cancer
20%
Retroperitoneal Lymph Node Dissection
20%
Hemodialysis
19%
Cancer
19%
Endoscopic Ultrasound
19%
Prognostic Factor
19%
Acute Coronary Syndrome
19%
Pediatrics
19%
Adenocarcinoma
18%
C Reactive Protein
18%
Pancreas Cancer
18%
Progression Free Survival
17%
Prevalence
17%
Postoperative Complication
17%
Robot-Assisted Surgery
17%
Body Mass Index
17%
Lymph Node Metastasis
17%
Cardiovascular System
17%
Glomerular Filtration Rate
17%
Pancreaticoduodenectomy
17%
Da Vinci Surgical System
16%
Drug-Eluting Stent
16%
Symptom
16%
Hepatocellular Carcinoma
16%
Surgical Anastomosis
15%
Meta-Analysis
15%
Retrospective Cohort Study
15%
ST Segment Elevation Myocardial Infarction
15%
Immune Checkpoint Inhibitor
15%
Operation Duration
14%
Kidney Function
14%
Carcinoma
14%
Lymph Node
14%
Systematic Review
14%
Neck
14%
Multidetector Computed Tomography
13%
Combination Therapy
13%
Frailty
13%
Prostate Cancer
13%
Heart Failure
13%
Cancer Surgery
13%
Atrial Fibrillation
13%
Clinical Feature
13%
Propensity Score Matching
13%
Myocardial Infarction
13%
Cardiovascular Disease
13%
Endoscopy
12%
Gastrointestinal Stromal Tumor
12%
Logistic Regression Analysis
12%
Cholangiocarcinoma
12%
Bevacizumab
12%
Acute Heart Infarction
12%
Biological Marker
12%
Cancer Cell
12%
Prospective Study
12%
Clinical Trial
11%
Narrow Band Imaging
11%
Biopsy
11%
Kidney Transplantation
11%
Prospective Cohort Study
11%
Diabetes Mellitus
11%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
62%
Chemotherapy
60%
Adverse Event
40%
Stomach Cancer
38%
Malignant Neoplasm
38%
Cohort Study
37%
Infection
34%
Neoplasm
33%
Overall Survival
32%
Non Small Cell Lung Cancer
26%
Colorectal Cancer
26%
Placebo
23%
Combination Therapy
22%
Progression Free Survival
22%
Mouse
21%
Retrospective Study
21%
C Reactive Protein
21%
Lipopolysaccharide
20%
Lung Cancer
19%
Cardiovascular Disease
19%
Biological Marker
19%
Immune Checkpoint Inhibitor
19%
Observational Study
18%
Symptom
18%
Hemodialysis
18%
Prevalence
17%
Bevacizumab
16%
Diseases
16%
Liver Cell Carcinoma
15%
Atrial Fibrillation
15%
Acute Heart Infarction
15%
Inflammation
15%
Acute Coronary Syndrome
15%
Coronary Artery Disease
15%
Heart Infarction
14%
Remission
14%
Randomized Controlled Trial
14%
Recurrent Disease
14%
Bleeding
13%
Cytokine
13%
Syndrome
13%
Monotherapy
13%
Epidermal Growth Factor Receptor
13%
Clinical Trial
13%
Pancreas Cancer
13%
ST Segment Elevation Myocardial Infarction
13%
All Cause Mortality
13%
Liver Metastasis
12%
Fluorouracil
12%
Survival Rate
12%
Heart Failure
11%
Prospective Study
11%
Coronavirinae
11%
Creatinine
11%
Antipsychotic
11%
Pembrolizumab
10%
Paclitaxel
10%
Clinical Feature
10%
Prostate Cancer
10%
Hospital Mortality
10%
Nivolumab
9%
Kidney Metastasis
9%
Diabetes Mellitus
9%
Atezolizumab
9%
Tumor Necrosis Factor
9%
Prospective Cohort Study
9%
Cisplatin
9%
Typical Antipsychotic
9%
Heart Death
9%
Immunotherapy
9%
Chronic Kidney Failure
8%
Brain Ischemia
8%
Stomach Carcinoma
8%
Statin (Protein)
8%
Anticoagulant Agent
8%
Human Herpesvirus 6
8%
Programmed Death 1 Ligand 1
8%
Metastatic Colorectal Cancer
8%
Ischemic Heart Disease
8%
Sepsis
8%
Aneurysm
7%
Atherosclerosis
7%
Major Depression
7%
Frailty
7%
Aripiprazole
7%
Nitric Oxide
7%
Vasculotropin
7%
Helicobacter Pylori
7%
Osimertinib
7%
Serum Albumin
7%
SARS Coronavirus
6%
Clinical Study
6%
Alzheimer's Disease
6%
Recurrence Risk
6%
Docetaxel
6%
Metabolic Syndrome X
6%
Crohn's Disease
6%
Obesity
6%
Protein P53
6%
Gemcitabine
6%
Keyphrases
Japan
50%
Confidence Interval
25%
Chemotherapy
19%
Gastric Cancer
16%
Non-small Cell Lung Cancer (NSCLC)
15%
Meta-analysis
13%
Japanese Population
13%
Percutaneous Coronary Intervention
12%
Clinical Outcomes
12%
Lipopolysaccharide
11%
Immune Checkpoint Inhibitors
11%
Overall Survival
11%
Major Depressive Disorder
11%
Lipopolysaccharide-induced
10%
Tumor
10%
Japanese Patients
10%
Hazard Ratio
10%
Odds Ratio
10%
Colorectal Cancer
10%
Schizophrenia
9%
Systematic Meta-analysis
9%
Programmed Death-ligand 1 (PD-L1)
8%
Retrospective Cohort Study
8%
Nitric Oxide Production
8%
Risk Factors
8%
No Significant Difference
8%
Multivariate Analysis
8%
5-fluorouracil (5-FU)
7%
Genotype
7%
Progression-free Survival
7%
Adverse Events
7%
Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)
7%
Chemoimmunotherapy
6%
Combination Therapy
6%
Monotherapy
6%
Prognostic Impact
6%
Hemodialysis Patients
6%
Computed Tomography
6%
Estimated Glomerular Filtration Rate
6%
Multicenter Cohort Study
6%
Orotate Phosphoribosyltransferase
6%
Acute Coronary Syndrome
6%
Prognostic Factors
6%
Rotavirus
6%
Resection
6%
Postoperative Outcomes
6%
Tumor Necrosis Factor-α
6%
Propensity Score Analysis
5%
Acute Myocardial Infarction
5%
Older Patients
5%
Gastric Carcinoma
5%
Single Center
5%
Pembrolizumab
5%
Minimally Invasive
5%
Vascular Endothelial Cells
5%
Human Herpesvirus 6 (HHV-6)
5%
Adjuvant Chemotherapy
5%
Liver
5%
Advanced Gastric Cancer
5%
Ulcerative Colitis
5%
Atezolizumab Plus Bevacizumab
5%
After Surgery
5%
Coronary Computed Tomography Angiography
5%
Atrial Fibrillation
5%
C-reactive Protein Level
5%
Postoperative Complications
5%
Gastrointestinal Stromal Tumor
5%
Adverse Cardiac Events
5%